| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥352.4B | ¥333.9B | +5.5% |
| Operating Income | ¥45.1B | ¥30.6B | +47.6% |
| Ordinary Income | ¥46.4B | ¥29.6B | +56.8% |
| Net Income | ¥32.4B | ¥20.0B | +61.4% |
| ROE | 10.7% | 7.2% | - |
FY2025 Q3 cumulative results showed revenue of 352.4B yen (YoY +5.5%), operating income of 45.1B yen (YoY +47.6%), ordinary income of 46.4B yen (YoY +56.8%), and net income of 32.4B yen (YoY +61.4%). The company achieved substantial profit growth significantly outpacing revenue expansion, driven by operating margin improvement to 12.8% from prior year 9.2%. Basic EPS increased 62.6% to 414.26 yen from 254.83 yen. Gross profit margin stood at 23.2%, while SG&A expenses ratio remained controlled at 10.4% of revenue. ROE reached 10.7%, reflecting improved profitability across the board. Total assets expanded to 481.1B yen with equity ratio maintained at healthy 62.9%.
Revenue increased 18.5B yen or 5.5% YoY to 352.4B yen, with all three reporting segments contributing to growth. The Chemicals segment, representing the core business with approximately 83.6% of total revenue, grew 4.3% YoY from 28.2B yen to 29.4B yen. The Electronic Materials segment showed strongest growth, expanding 63.7% from 1.1B yen to 1.8B yen, though from a smaller base. The Machinery segment remained relatively flat at approximately 3.0B yen with slight decline of 1.6%.
Operating income surged 14.5B yen or 47.6% to 45.1B yen, with operating margin expanding 3.6 percentage points to 12.8% from 9.2%. This substantial margin improvement stemmed from gross profit margin expansion to 23.2% combined with effective SG&A cost control. Cost of sales increased only 3.8% to 270.7B yen while revenue grew 5.5%, indicating improved cost efficiency or favorable product mix shift. SG&A expenses rose modestly to 36.6B yen (10.4% of revenue) from prior levels, demonstrating operating leverage benefits.
Ordinary income increased 16.8B yen or 56.8% to 46.4B yen, slightly outpacing operating income growth. The ordinary-to-operating income differential of 1.3B yen reflects net non-operating income contribution, comprising financial income of 3.6B yen offset by interest expense of 0.9B yen. Interest coverage ratio stands at approximately 49x (operating income divided by interest expense), indicating minimal financial burden.
Net income advanced 12.4B yen or 61.4% to 32.4B yen. The gap between pre-tax profit (46.4B yen) and net income reflects an effective tax rate of approximately 30.2%, yielding a tax burden coefficient of 0.698. No material extraordinary items or impairment losses were disclosed, suggesting earnings quality remains supported by recurring operations.
This represents a revenue up, profit up pattern, with profit growth significantly exceeding revenue growth due to margin expansion and operational efficiency gains.
The Chemicals segment generated revenue of 29.4B yen (YoY +4.3%) and segment profit of 4.2B yen (YoY +21.6%), representing the core business with 83.6% revenue share. Segment profit margin improved to 14.1% from 12.1% prior year, reflecting operational efficiency gains. The Machinery segment recorded revenue of 3.0B yen (YoY -1.6%) with segment profit of 0.2B yen, recovering from prior year loss of 0.2B yen, demonstrating a turnaround in profitability despite modest revenue decline. The Electronic Materials segment achieved revenue of 1.8B yen (YoY +63.7%) with segment profit of 0.6B yen (YoY +456%), representing the highest growth rate among segments with profit margin expansion to 30.4% from 9.0%. The Other segment contributed revenue of 0.9B yen and profit of 0.6B yen, remaining stable. Unallocated corporate expenses increased to 1.0B yen from 0.9B yen, primarily consisting of general administrative and R&D costs not attributable to specific segments. The Chemicals segment dominates profitability with 84.3% of total segment profit before corporate adjustments, while Electronic Materials shows highest margin profile at 30.4%, suggesting potential for future growth contribution as scale increases.
[Profitability] ROE of 10.7% exceeds industry median of 5.8% by 4.9 percentage points, positioning the company in the upper performance tier. Operating margin of 12.8% compares favorably to industry median of 8.9%, reflecting 3.9 percentage point advantage. Net profit margin of 9.2% substantially exceeds industry median of 6.5% by 2.7 percentage points. ROA reached 6.7% (calculated as net income 32.4B yen divided by total assets 481.1B yen), outperforming industry median of 3.4% by 3.3 percentage points. DuPont analysis reveals ROE composition of net profit margin 9.2%, total asset turnover 0.732x, and financial leverage 1.59x, with profitability being the primary driver. [Cash Quality] Cash and deposits totaled 38.6B yen with short-term debt coverage ratio of 0.75x (cash divided by short-term loans of 51.2B yen), indicating cash holdings cover approximately 75% of short-term borrowings. Inventories stood at 38.2B yen, representing 10.8% of total assets. [Investment Efficiency] Total asset turnover of 0.732x (annualized revenue 469.9B yen divided by total assets 481.1B yen) exceeds industry median of 0.56x, demonstrating superior asset utilization efficiency. Return on invested capital of 9.4% (approximated) compares favorably to industry median of 6.0%. [Financial Health] Equity ratio of 62.9% aligns closely with industry median of 63.8%, maintaining industry-standard financial stability. Current ratio of 198.8% substantially exceeds industry median of 287%, though still indicates adequate short-term liquidity. Debt-to-equity ratio of 0.59x (interest-bearing debt 77.0B yen divided by equity 302.6B yen) reflects conservative leverage. Financial leverage of 1.59x matches industry median of 1.53x closely, indicating balanced capital structure.
Cash and deposits decreased from 39.3B yen to 38.6B yen, representing a reduction of 0.7B yen despite strong net income generation of 32.4B yen, suggesting significant cash outflows in investing or financing activities. Working capital movements show accounts receivable increased to 122.4B yen, with receivables turnover extending to approximately 127 days (annualized), exceeding the industry median of 85 days by 42 days, indicating slower collection efficiency and potential cash conversion pressure. Inventories expanded to 38.2B yen with turnover estimated at 104 days (annualized), comparing favorably to industry median of 112 days. Accounts payable stood at 63.8B yen with payables turnover of approximately 86 days (annualized), exceeding industry median of 56 days by 30 days, reflecting extended payment terms and effective supplier credit utilization. The cash conversion cycle approximates 145 days (receivables 127 days plus inventory 104 days minus payables 86 days), substantially exceeding industry median of 111 days by 34 days, highlighting working capital efficiency as an area warranting attention. Construction-in-progress surged from 7.2B yen to 25.6B yen, indicating 18.4B yen of capital deployment for facility expansion or new production capacity. Long-term borrowings decreased from 40.0B yen to 25.8B yen, suggesting 14.2B yen debt repayment, partially offset by increased short-term borrowings. The combination of working capital absorption, capital investment, and debt restructuring explains the net cash position decline despite robust earnings. Short-term debt coverage of 0.75x indicates refinancing exposure requiring monitoring.
Ordinary income of 46.4B yen versus operating income of 45.1B yen shows non-operating net contribution of approximately 1.3B yen, representing 0.4% of revenue. This comprises primarily non-operating income of 3.6B yen, including interest and dividend income, partially offset by non-operating expenses of 2.3B yen including interest expense of 0.9B yen. The non-operating impact remains modest relative to core operating performance, indicating earnings are predominantly driven by business operations rather than financial activities. No material extraordinary items, asset impairments, or restructuring charges were disclosed for the period, suggesting reported earnings reflect sustainable run-rate performance. The absence of detailed cash flow statement data for the quarterly period limits direct operating cash flow to net income comparison, however balance sheet analysis reveals working capital absorption through extended receivables turnover (127 days versus industry 85 days), indicating potential earnings quality concern regarding cash conversion efficiency. The receivables buildup suggests revenue recognition may precede cash collection by a wider margin than industry peers, warranting monitoring of collection quality and potential bad debt exposure. Conversely, the strong operating margin expansion from 9.2% to 12.8% and sustained gross margin at 23.2% demonstrate underlying business profitability improvements that support earnings sustainability, provided working capital metrics normalize.
Full-year guidance projects revenue of 477.0B yen (YoY +5.0%), operating income of 58.0B yen (YoY +22.5%), and ordinary income of 60.0B yen (YoY +30.4%). Q3 cumulative progress rates stand at 73.9% for revenue, 77.8% for operating income, and 77.3% for ordinary income against full-year targets. Revenue progress of 73.9% tracks slightly below the standard 75% threshold for Q3, suggesting Q4 revenue acceleration of approximately 124.6B yen is required, representing 35.4% of annual target in the final quarter. Operating income progress of 77.8% exceeds the standard 75% benchmark by 2.8 percentage points, indicating the company is running ahead of pace on profitability. The ahead-of-schedule profit progress despite slightly behind-schedule revenue suggests continued margin expansion trajectory or potential conservative full-year guidance. Q4 implied operating income of 12.9B yen would represent 28.6% operating margin on implied Q4 revenue, materially above the 12.8% margin achieved in Q3 cumulative period, suggesting either seasonality factors, project completions, or guidance conservatism. Annual EPS forecast of 537.61 yen implies full-year net income of approximately 42.0B yen based on average shares outstanding of 7,810 thousand shares, with Q3 cumulative net income of 32.4B yen representing 77.1% progress. The construction-in-progress increase of 18.4B yen to 25.6B yen indicates significant capital projects underway, though timing of commercial operation and revenue contribution remains undisclosed in available guidance materials.
Annual dividend forecast stands at 106.00 yen per share, comprising interim dividend of 48.00 yen and year-end dividend of 58.00 yen (note: the forecast shows 72 yen interim + year-end structure totaling 106 yen based on guidance data). Based on forecast EPS of 537.61 yen, the payout ratio calculates to 19.7%. Using Q3 cumulative actual EPS of 414.26 yen as reference, the annualized payout ratio would approximate 25.6%. Historical comparison data is not provided in the available dataset, limiting YoY dividend growth assessment. The forecast payout ratio of approximately 19.7-25.6% positions well below typical Japanese corporate payout ranges of 30-40%, indicating conservative distribution policy with substantial earnings retention for reinvestment. Given the construction-in-progress surge indicating active capital deployment, the relatively low payout ratio aligns with growth investment phase strategy. No share buyback program disclosure is provided in the available data. The dividend coverage appears sustainable given the payout ratio level, though cash flow generation quality relative to reported earnings warrants monitoring given the extended receivables collection cycle of 127 days versus industry median of 85 days.
Working capital management represents the primary operational risk, with accounts receivable turnover of 127 days exceeding industry median by 42 days and cash conversion cycle of 145 days exceeding industry median by 34 days. The extended collection period absorbs approximately 41.7B yen in working capital (receivables less industry-normalized level), constraining cash generation and potentially indicating customer credit quality concerns or contractual payment term challenges. If collection efficiency does not improve, the company faces heightened risk of cash flow pressure despite strong reported profitability. Refinancing exposure constitutes the second material risk, with short-term debt ratio of 66.5% and short-term loans of 51.2B yen substantially exceeding cash holdings of 38.6B yen, creating 12.6B yen funding gap. The company's shift from long-term borrowings (decreased 14.2B yen) toward short-term debt structure increases vulnerability to credit market disruptions or interest rate volatility. Capital investment execution and return realization represents the third key risk, with construction-in-progress surging 257% to 25.6B yen. The 18.4B yen capital deployment requires successful project completion and commercial operation to generate forecast returns. Project delays, cost overruns, or demand shortfalls could impair the 77.0B yen interest-bearing debt servicing capacity, particularly given the debt refinancing structure weighted toward short-term obligations.
[Industry Position] (Reference - Proprietary Analysis) Profitability metrics demonstrate strong competitive positioning, with ROE of 10.7% substantially exceeding industry median of 5.8% by 4.9 percentage points, ranking in the upper performance quartile. Operating margin of 12.8% surpasses industry median of 8.9% by 3.9 percentage points, while net profit margin of 9.2% exceeds industry median of 6.5% by 2.7 percentage points. ROA of 6.7% outperforms industry median of 3.4% by 3.3 percentage points, indicating superior asset utilization and profitability combination. Financial health indicators show equity ratio of 62.9% aligned with industry median of 63.8%, maintaining industry-standard balance sheet stability. Current ratio of 198.8% falls below industry median of 287% by 88 percentage points, though remaining adequate for liquidity needs. Net debt to EBITDA positioning relative to industry median of -1.11x cannot be precisely determined from quarterly data, though the company's positive net debt position contrasts with the industry's net cash position. Efficiency metrics reveal asset turnover of 0.732x substantially exceeds industry median of 0.56x by 0.172x or 30.7%, demonstrating superior revenue generation per asset unit deployed. Revenue growth of 5.5% YoY exceeds industry median of 2.8% by 2.7 percentage points, while EPS growth of 62.6% dramatically outperforms industry median of 9.0% by 53.6 percentage points, reflecting the company's margin expansion achievement. Working capital efficiency presents competitive weakness, with receivables turnover of 127 days exceeding industry median of 85 days by 42 days (49% longer), though inventory turnover of 104 days compares favorably to industry median of 112 days. Payables turnover of 86 days exceeds industry median of 56 days by 30 days (53% longer), offsetting some receivables pressure. Overall cash conversion cycle of 145 days exceeds industry median of 111 days by 34 days (31% longer), positioning below industry efficiency standards despite strong profitability performance.
(Industry: Manufacturing, N=105 companies for most metrics, Comparison: FY2025 Q3 cross-sectional, Source: Proprietary analysis)
Strong profitability expansion with operating margin improving 3.6 percentage points to 12.8% and ROE of 10.7% substantially exceeding manufacturing industry median of 5.8% demonstrates competitive advantage in core Chemicals business and high-margin Electronic Materials segment growth. The company's profit growth of 47.6% operating income and 61.4% net income significantly outpacing revenue growth of 5.5% reflects successful operational efficiency initiatives and favorable business mix evolution, particularly Electronic Materials segment profit surge of 456% YoY.
Working capital efficiency deterioration presents the primary concern for earnings quality sustainability, with receivables collection cycle of 127 days exceeding industry median by 42 days and overall cash conversion cycle of 145 days exceeding industry median by 34 days. The 122.4B yen receivables balance represents 34.7% of revenue, substantially above typical manufacturing norms, indicating either extended contractual payment terms or collection execution challenges. This working capital absorption constrains cash generation relative to reported earnings strength and warrants monitoring for potential credit quality issues.
Capital deployment strategy evidenced by construction-in-progress surge of 18.4B yen to 25.6B yen combined with refinancing structure shift from long-term to short-term debt (short-term debt ratio 66.5%) creates both growth opportunity and financial risk. Successful project execution and revenue contribution from new capacity would support the company's above-industry growth trajectory, while project delays or demand shortfalls combined with refinancing pressure could stress the financial structure given short-term loans of 51.2B yen exceed cash holdings of 38.6B yen by 12.6B yen.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.